POMGNT1 and muscular dystrophy-dystroglycanopathy, type A: POMT2 and POMGNT1 are involved in two clinically similar disorders, respectively Walker–Warburg syndrome (WWS) and muscle–eye–brain disease (MEB) [50, 51].